Loading clinical trials...
Loading clinical trials...
Assessment of Macrophage Activation syndromE in STill's Disease: Retrospective Chart Analysis of Patient HistorY, Symptom Resolution and Treatment Characteristics
Conditions
Interventions
Chart review
Locations
11
United States
Swedish Orphan Biovitrum Research Site
Los Angeles, California, United States
Swedish Orphan Biovitrum Research Site
Atlanta, Georgia, United States
Swedish Orphan Biovitrum Research Site
Cincinnati, Ohio, United States
Swedish Orphan Biovitrum Research Site
Philadelphia, Pennsylvania, United States
Swedish Orphan Biovitrum Research Site
Calgary, Canada
Swedish Orphan Biovitrum Research Site
Paris, France
Start Date
September 27, 2023
Primary Completion Date
September 26, 2024
Completion Date
September 26, 2024
Last Updated
October 21, 2024
NCT05927454
NCT05814159
NCT05715736
NCT03311854
NCT03332225
NCT01095146
Lead Sponsor
Swedish Orphan Biovitrum
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions